Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Genetically Determined Blood Pressure, Antihypertensive Medications, and Risk of Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:56
  • Read more about Genetically Determined Blood Pressure, Antihypertensive Medications, and Risk of Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Study

Eye-brain connections revealed by multimodal retinal and brain imaging genetics

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:54
  • Read more about Eye-brain connections revealed by multimodal retinal and brain imaging genetics

Genome-wide association study of traumatic brain injury in U.S. military veterans enrolled in the VA million veteran program

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:51
  • Read more about Genome-wide association study of traumatic brain injury in U.S. military veterans enrolled in the VA million veteran program

Effect of gastroesophageal reflux disease on sleep disorders: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:48
  • Read more about Effect of gastroesophageal reflux disease on sleep disorders: a Mendelian randomization study

Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:45
  • Read more about Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study

A FinnGen pilot clinical recall study for Alzheimer's disease

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:41
  • Read more about A FinnGen pilot clinical recall study for Alzheimer's disease

Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:38
  • Read more about Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study

Genetic evidence that high BMI in childhood has a protective effect on intermediate diabetes traits, including measures of insulin sensitivity and secretion, after accounting for BMI in adulthood

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:34
  • Read more about Genetic evidence that high BMI in childhood has a protective effect on intermediate diabetes traits, including measures of insulin sensitivity and secretion, after accounting for BMI in adulthood

Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:31
  • Read more about Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals

Multi-ancestry GWAS analysis identifies two novel loci associated with diabetic eye disease and highlights APOL1 as a high risk locus in patients with diabetic macular edema

Submitted by Frida Mäkelä on Wed, 03/29/2023 - 11:24
  • Read more about Multi-ancestry GWAS analysis identifies two novel loci associated with diabetic eye disease and highlights APOL1 as a high risk locus in patients with diabetic macular edema

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 372
  • Page 373
  • Page 374
  • Page 375
  • Current page 376
  • Page 377
  • Page 378
  • Page 379
  • Page 380
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement